Expression of Plk1 and MUC4 Gene in Pancreatic Carcinoma and Their Clinical Significance

ZHU Yi,ZHAO Wen-yu,GAO Wen-tao,PENG Tao,XU Ze-kuan,MIAO Yi
DOI: https://doi.org/10.3969/j.issn.1007-4368.2005.11.003
2005-01-01
Abstract:Objective: To determine the expression status of Plk1 and MUC4 genes in pancreatic carcinoma. Methods: Expression of Plk1 and MUC4 genes was evaluated by immunohistochemistry in 33 cases of pancreatic carcinoma along with their corresponding adjacent benign tissues, 3 cases of pancreatic serous cystadenoma, 3 cases of pancreatic mucinous cystadenoma and 5 cases of chronic pancreatitis. Results:The positive expression rate of Plk1 and MUC4 genes in pancreatic carcinoma was 72.7%(24/33) and 51.5%(17/33), respectively. There was no relationship between the expression of Plk1 and MUC4 genes and patients'age, sex, clinical staging, histologic grading, nodes invasion and the location of the tumor (P 0.05). No expression of Plk1 and MUC4 genes was detected in benign tissue adjacent to the tumors, chronic pancreatitis and benign pancreatic tumors. Conclusion:The expression of Plk1 and MUC4 genes appears to be tumor specific to some extent in our pancreatic carcinoma samples. Plk1 and MUC4 may be two ideal targets for therapy against pancreatic carcinoma.
What problem does this paper attempt to address?